Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?-Reference-Cited by-同舟云学术

Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?

Published:2021-03-09 Issue:7 Volume:81 Page:377-389
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Tamalunas Alexander¹^ORCID,Sauckel Cora¹,Ciotkowska Anna¹,Rutz Beata¹,Wang Ruixiao¹,Huang Ru¹,Li Bingsheng¹,Stief Christian G.¹^ORCID,Gratzke Christian²^ORCID,Hennenberg Martin¹^ORCID

Affiliation:

1. Department of Urology University Hospital, LMU Munich Munich Germany

2. Department of Urology University of Freiburg Freiburg Germany

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24114

Reference51 articles.

1. GravasS CornuJN DrakeMJ et al. Management of non‐neurogenic male LUTS. EAU Guidelines Edn. Presented at: EAU Annual Congress; March 16‐20 2018; Copenhagen Denmark.

2. Prostatic α1-adrenoceptors: New concepts of function, regulation, and intracellular signaling

3. Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of ur

4. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

5. Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing prostate zonal shape changes associated with 5α‐reductase inhibitors using MRI;Clinical Anatomy;2024-08-20

2. Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions;Biomedicine & Pharmacotherapy;2024-08

3. Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates;Journal of Personalized Medicine;2024-04-01

4. Early investigational agents for the treatment of benign prostatic hyperplasia’;Expert Opinion on Investigational Drugs;2024-03-04

5. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate;Journal of Translational Medicine;2023-08-26